Erudio Healtherudio.com
Indication
Chronic lymphocytic leukemia trials: what clinicians said in public
No HCP commentary report on a trial in chronic lymphocytic leukemia yet. Erudio has found public clinician commentary on 4 clinical trials in chronic lymphocytic leukemia: CLL2-BZAG, CLL11, CLL17 and NCT02500407. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CLL17 NCT04608318 · German CLL Study Group DeepView → | previously untreated chronic lymphocytic leukemia | Phase 3 | Deep | View | |||
| CLL11 NCT01010061 · Hoffmann-La Roche DeepView → | previously untreated chronic lymphocytic leukemia with comorbidities | Phase 3 | Deep | View | |||
| CLL2-BZAG NCT04515238 · German CLL Study Group FocusedView → | relapsed/refractory CLL | Phase 2 | Focused | View | |||
| NCT02500407 NCT02500407 · Genentech, Inc. FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||